Jun Zhu: Clinical Trials

2 trials sponsored by Jun Zhu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown, 1 withdrawn. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 1, Withdrawn 1

Follow Jun Zhu: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Tropisetron, Dexamethasone, Aprepitant - Vomiting
Phase 4UnknownJun Zhu1302015-10-012016-12-30
A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib
crizotinib - Systemic Anaplastic Large-Cell Lymphoma
Phase 4WithdrawnJun Zhu2015-07-012016-12-30

Conditions studied

Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Vomiting (1)

Interventions

Aprepitant (1)  ·  Crizotinib (1)  ·  Dexamethasone (1)  ·  R-CHOP protocol (1)  ·  Tropisetron (1)  ·  dexamethasone 21-phosphate (1)

Countries

China (1)

Results publications

PMID 25559471